Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study

K. Samara, K. Antoniou, I. Giannarakis, I. Lasithiotaki, A. Psaraki, G. Soufla, P. Sidiropoulos, N. Siafakas (Heraklion, Greece)

Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Session: Pathogenesis and risk of lung cancer
Session type: Thematic Poster Session
Number: 4516

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Samara, K. Antoniou, I. Giannarakis, I. Lasithiotaki, A. Psaraki, G. Soufla, P. Sidiropoulos, N. Siafakas (Heraklion, Greece). Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study. Eur Respir J 2013; 42: Suppl. 57, 4516

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Feroptosis of alveolar macrophages in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Bronchoalveolar lavage in patients with acute lung toxicity after chemo-radiotherapy for lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013


What surgery for which bronchiolo-alveolar carcinoma?
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Surfactant changes in patients with lung cancer underwent to resection
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009